Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Related Articles by Review for PubMed (Select 17089217)

1.

Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome.

Thomas JA, Jacobs S, Kierstein J, Van Hove J.

J Inherit Metab Dis. 2006 Dec;29(6):762. Epub 2006 Nov 6.

PMID:
17089217
2.

Laronidase.

[No authors listed]

BioDrugs. 2002;16(4):316-8. Review.

PMID:
12196045
3.

Laronidase treatment of mucopolysaccharidosis I.

Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA.

BioDrugs. 2005;19(1):1-7. Review.

PMID:
15691212
4.

Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I.

Jameson E, Jones S, Wraith JE.

Cochrane Database Syst Rev. 2013 Sep 26;9:CD009354. doi: 10.1002/14651858.CD009354.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;11:CD009354.

PMID:
24085657
5.

Enzyme replacement therapy with laronidase (Aldurazyme(®)) for treating mucopolysaccharidosis type I.

Jameson E, Jones S, Wraith JE.

Cochrane Database Syst Rev. 2013 Nov 21;11:CD009354. doi: 10.1002/14651858.CD009354.pub3. Review.

PMID:
24257962
6.
7.

Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.

Brooks DA.

Expert Opin Biol Ther. 2002 Dec;2(8):967-76. Review.

PMID:
12517274
8.

Mucopolysaccharidosis type I.

Wraith JE, Jones S.

Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6. Review.

PMID:
25345091
9.

Enzyme replacement therapy in mucopolysaccharidosis type I.

Miebach E.

Acta Paediatr Suppl. 2005 Mar;94(447):58-60; discussion 57. Review.

PMID:
15895714
10.

Mucopolysaccharidosis Type I.

Clarke LA, Heppner J.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015.
2002 Oct 31 [updated 2011 Jul 21].

11.

Laronidase (Aldurazyme): enzyme replacement therapy for mucopolysaccharidosis type I.

Pastores GM.

Expert Opin Biol Ther. 2008 Jul;8(7):1003-9. doi: 10.1517/14712598.8.7.1003 . Review.

PMID:
18549329
12.

Therapy for the mucopolysaccharidoses.

Valayannopoulos V, Wijburg FA.

Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v49-59. doi: 10.1093/rheumatology/ker396. Review.

13.

Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.

de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, Mengel E, Offringa M, O'Meara A, Parini R, Rovelli A, Sykora KW, Valayannopoulos V, Vellodi A, Wynn RF, Wijburg FA.

Orphanet J Rare Dis. 2011 Aug 10;6:55. doi: 10.1186/1750-1172-6-55.

14.

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.

Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brooks DA.

Lancet. 2003 May 10;361(9369):1608-13. Review.

PMID:
12747881
15.

Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties.

Wraith JE.

J Inherit Metab Dis. 2001 Apr;24(2):245-50. Review.

PMID:
11405343
16.

[Mucopolysaccharidosis IS: Scheie's syndrome. A report of 2 brothers].

Bonora G, Frattini D, Nedbal M, Massironi C, Perletti L.

Pediatr Med Chir. 1991 Nov-Dec;13(6):631-6. Review. Italian.

PMID:
1839643
17.

Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review.

Braunlin E, Orchard PJ, Whitley CB, Schroeder L, Reed RC, Manivel JC.

Cardiovasc Pathol. 2014 May-Jun;23(3):145-51. doi: 10.1016/j.carpath.2014.01.001. Epub 2014 Jan 10. Review.

PMID:
24508139
18.

[Overview of enzyme replacement therapy in mucopolysaccharidosis].

Fouilhoux A, Guffon N.

Presse Med. 2007 Mar;36 Spec No 1:1S96-9. Review. French.

PMID:
17546776
19.

A nonpathologic allele (IW) for low alpha-L-iduronidase enzyme activity vis-a-vis prenatal diagnosis of Hurler syndrome.

Whitley CB, Gorlin RJ, Krivit W.

Am J Med Genet. 1987 Sep;28(1):233-43. Review.

PMID:
3118714
20.

[Hurler syndrome(MPS IH), Scheie syndrome(MPS IS)].

Matsushita Y, Kuroiwa Y.

Ryoikibetsu Shokogun Shirizu. 2000;(29 Pt 4):460-1. Review. Japanese. No abstract available.

PMID:
11031992
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk